Are you ready to kickstart your journey towards a healthier lifestyle? The YMCA announces the 2025 launch of a National Diabetes Prevention Program aimed at anyone looking to take control of their ...
REDEFINE 1 – a 68-week efficacy and safety phase 3 trial of once-weekly CagriSema, cagrilintide 2.4 mg and semaglutide 2.4 mg versus placebo in 3,400 adults with obesity or overweight with one or more ...